Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD

F. Cruz-González,L. Cabrillo Estévez,Gloria López-Valverde,Clara Cieza-Borrella,Emiliano Hernández Galilea,Rogelio González Sarmiento

Predictive value of VEGF A and VEGFR2 polymorphisms in the response to intravitreal ranibizumab treatment for wet AMD

2014

F. Cruz-González
L. Cabrillo Estévez
Gloria López-Valverde
Clara Cieza-Borrella
Emiliano Hernández Galilea
Rogelio González Sarmiento

Background To determine whether gene polymorphisms of the vascular endothelial growth factor A (VEGF A) and its receptor (VEGFR) influence the response to a variable-dosing treatment regimen with ranibizumab for age-related macular degeneration.

Keywords:

Macular degeneration
Anatomy
Ranibizumab
Regimen
Vascular endothelial growth factor A
VEGF receptors
Medicine
Fluorescein angiography
Oncology
Diabetes mellitus
Receptor
Prospective cohort study
Internal medicine
Kinase insert domain receptor

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations